We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.11%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$338B
AUM Growth
+$13.2B
(+4.1%)
Cap. Flow
-$8.05B
Cap. Flow
% of AUM
-2.38%
Top 10 Holdings %
Top 10 Hldgs %
23.21%
Holding
3,478
New
75
Increased
881
Reduced
2,243
Closed
162
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nuveen Growth Opportunities ETF
NUGO
|
+$3.24B |
| 2 |
Palo Alto Networks
PANW
|
+$489M |
| 3 |
Tesla
TSLA
|
+$372M |
| 4 |
Qualcomm
QCOM
|
+$361M |
| 5 |
Broadcom
AVGO
|
+$351M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.18B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$662M |
| 3 |
Amazon
AMZN
|
+$544M |
| 4 |
Apple
AAPL
|
+$540M |
| 5 |
Meta Platforms (Facebook)
META
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.36% |
| 2 | Consumer Discretionary | 12.42% |
| 3 | Healthcare | 12.26% |
| 4 | Financials | 12.2% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Scholar Rock
SRRK
$6.44B
| $2.54M | ﹤0.01% |
102,317
+9,914
| +11% | +$274K |
|
|
DNMR
2452
DELISTED
Danimer Scientific, Inc.
DNMR
| $2.54M | ﹤0.01% |
5,955
+532
| +10% | +$293K |
|
2453
Olema Pharmaceuticals
OLMA
$1.05B
| $2.52M | ﹤0.01% |
289,443
-8,059
| -3% | -$167K |
|
2454
Community Trust Bancorp
CTBI
$1.41B
| $2.52M | ﹤0.01% |
57,797
-4,651
| -7% | -$203K |
|
|
KDNY
2455
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $2.52M | ﹤0.01% |
154,336
-23,819
| -13% | -$339K |
|
|
KRON
2456
DELISTED
Kronos Bio
KRON
| $2.52M | ﹤0.01% |
185,124
+2,884
| +2% | +$45.1K |
|
2457
Tucows
TCX
$175M
| $2.51M | ﹤0.01% |
30,588
-2,696
| -8% | -$225K |
|
|
PRVB
2458
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $2.51M | ﹤0.01% |
445,960
+8,335
| +2% | +$52.9K |
|
2459
Kopin
KOPN
$791M
| $2.5M | ﹤0.01% |
611,972
-37,401
| -6% | -$190K |
|
|
SGFY
2460
DELISTED
Signify Health, Inc.
SGFY
| $2.5M | ﹤0.01% |
175,906
-11,115
| -6% | -$172K |
|
2461
Nurix Therapeutics
NRIX
$2.65B
| $2.49M | ﹤0.01% |
94,777
-7,082
| -7% | -$215K |
|
|
TRST
2462
Trustco Bank Corp NY
TRST
$938M
| $2.49M | ﹤0.01% |
77,215
-4,537
| -6% | -$151K |
|
2463
Lands' End
LE
$403M
| $2.49M | ﹤0.01% |
126,709
+3,605
| +3% | +$83.8K |
|
2464
Tootsie Roll Industries
TR
$2.98B
| $2.49M | ﹤0.01% |
74,017
-6,432
| -8% | -$186K |
|
2465
IDEAYA Biosciences
IDYA
$3.56B
| $2.48M | ﹤0.01% |
116,851
-8,012
| -6% | -$186K |
|
2466
Luxfer Holdings
LXFR
$458M
| $2.48M | ﹤0.01% |
128,665
-9,337
| -7% | -$190K |
|
2467
Precigen
PGEN
$2.59B
| $2.48M | ﹤0.01% |
711,419
+123,923
| +21% | +$533K |
|
2468
Future Fuel
FF
$223M
| $2.46M | ﹤0.01% |
343,784
+223,633
| +186% | +$1.74M |
|
2469
Hovnanian Enterprises
HOV
$807M
| $2.45M | ﹤0.01% |
21,156
+1,053
| +5% | +$104K |
|
2470
Itaú Unibanco
ITUB
$87.5B
| $2.44M | ﹤0.01% |
737,968
-210,518
| -22% | -$758K |
|
2471
Scorpio Tankers
STNG
$3.81B
| $2.44M | ﹤0.01% |
190,736
-12,539
| -6% | -$193K |
|
|
NREF
2472
NexPoint Real Estate Finance
NREF
$342M
| $2.43M | ﹤0.01% |
126,194
-3,600
| -3% | -$74.2K |
|
2473
Bank of Marin Bancorp
BMRC
$459M
| $2.42M | ﹤0.01% |
67,619
-3,552
| -5% | -$133K |
|
2474
Ocular Therapeutix
OCUL
$2.02B
| $2.42M | ﹤0.01% |
389,548
+61,028
| +19% | +$474K |
|
2475
Mission Produce
AVO
$1.17B
| $2.42M | ﹤0.01% |
137,439
-17,693
| -11% | -$329K |
|
Similar funds
VFT
Nuveen's Q4 2021 Portfolio in Review
As of Q4 2021, Nuveen held 3,478 positions worth $338B, up 4.1% from $325B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q4 2021 filing shows 75 new, 881 increased, 2,243 reduced and 162 closed positions. Its largest new stake was Roblox: 1,368,944 shares worth $141M. The largest sale was iShares Russell 1000 Growth ETF, an estimated $1.18B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Nuveen's largest Q4 2021 buy was Roblox: 1,368,944 shares worth $141M.
- Nuveen added most to Nuveen Growth Opportunities ETF in Q4 2021, an estimated $3.24B increase.
- Nuveen's biggest Q4 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $1.18B.
- Nuveen fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $102M.
- Nuveen's ten largest holdings make up 23% of its $338B portfolio in Q4 2021.
- Nuveen opened 75 new positions and closed 162 in Q4 2021.
- Nuveen's portfolio value rose 4.1% quarter-over-quarter to $338B.
Based on Nuveen's 13F filing for Q4 2021, filed 14 Feb 2022.